Frontiers in genetics

Diabetic Kidney Disease: Using Multiple Biological Data, Artificial Intelligence, and New Treatments for Personalized Care

Updated

Abstract

Recent advances in diabetic kidney disease (DKD) research highlight novel biomarkers associated with mitochondrial dysfunction and oxidative stress.

  • Single-cell RNA sequencing and spatial transcriptomics reveal significant cellular diversity and identify maladaptive tubular cell states linked to disease progression.
  • Immune dysregulation is recognized as a central factor in the progression of DKD.
  • Metabolomics has uncovered early metabolic disturbances that could serve as biomarkers for the disease.
  • Artificial intelligence models, such as DeepDKD, show high accuracy in non-invasive screening using retinal images.
  • Novel therapeutic agents are being developed to target inflammation, fibrosis, and metabolic pathways beyond traditional treatments.

Simplified

Full Text

Full text is available at the source.

Funding

Competing interests

The author(s) declared that this work was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
PubMed

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • ✅direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free